IE 11 is not supported. For an optimal experience visit our site on another browser.
  • Amid omicron, should holiday gatherings and return-to-office plans change?

    04:11
  • How to manage holiday stress and combat ‘emotional vampires’

    04:53
  • Vaccine boosters, travel, holiday parties: Your omicron questions answered

    04:56
  • Meet the runner who’s out to prove that fitness fits all sizes

    04:16
  • Bishop and rabbi offer timely perspective on how to give thanks

    06:16
  • How St. Jude saved one little girl’s life with a bone marrow transplant

    05:02
  • Race is on for booster shots and COVID tests ahead of holiday gatherings

    02:06
  • What to know about diabetes: Symptoms, risk factors, how to manage it

    05:02
  • Could foods from the first Thanksgiving help you live longer?

    05:34
  • Music is 'a new language' for these Alzheimer's patients and caregivers

    05:00
  • U.S. Surgeon General gives updates on COVID-19 booster shots and more

    05:42
  • How to navigate holiday travel (and vaccine etiquette) this Thanksgiving

    04:52
  • Tips and tricks to improve brain health and manage Alzheimer's disease

    06:25
  • How to navigate health insurance, open enrollment, FSA

    04:33
  • Dr. Natalie Azar shares what you need to know about Pfizer boosters for adults

    03:22
  • New research reveals the best time to go to bed is…

    03:03
  • Hoda and 'Jumping Jenna' try this trendy trampoline workout

    02:50
  • Trouble sleeping? These 6 products will help

    03:16
  • First responders team up with Alzheimer’s patients and caregivers

    04:19
  • New research shows how psychedelic drug can help people with PTSD

    06:59

FDA expected to approve esketamine nasal spray

04:25

The FDA is set to approve SPRAVATOTM, an esketamine nasal spray that could help certain patients with severe depression. Dr. Drew Ramsey joins TODAY to explain.